Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Myeloid 3Lymphoid 3Plasma cell 2Other hematologic neoplasm 2Classical hematology 1

Conditions

Myelodysplastic Syndromes 47Leukemia, Myeloid, Acute 42Precursor Cell Lymphoblastic Leukemia-Lymphoma 39Leukemia 26Leukemia, Myelogenous, Chronic, BCR-ABL Positive 25Lymphoma, Non-Hodgkin 23Lymphoma 15Hodgkin Disease 13Leukemia, Myeloid, Accelerated Phase 12Leukemia, Lymphocytic, Chronic, B-Cell 11Leukemia, Biphenotypic, Acute 11Blast Crisis 11Myeloproliferative Disorders 10Anemia, Refractory, with Excess of Blasts 10Multiple Myeloma 9Leukemia, Myelomonocytic, Juvenile 8Leukemia, Myeloid, Chronic-Phase 8Hematologic Neoplasms 8Congenital Abnormalities 8Graft vs Host Disease 7Burkitt Lymphoma 7Primary Myelofibrosis 6Myelodysplastic-Myeloproliferative Diseases 6Leukemia, Myelomonocytic, Chronic 6Polycythemia Vera 4Lymphoma, Mantle-Cell 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Follicular 4Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 4Dendritic Cell Sarcoma, Interdigitating 4

Interventions

Cyclophosphamide 10fludarabine 8Mycophenolic Acid 7Tacrolimus 6Melphalan 6ruxolitinib 5fludarabine phosphate 5Imatinib Mesylate 5Busulfan 5Bone Marrow Transplantation 5ponatinib 4Mesna 4Azacitidine 4nilotinib 3Whole-Body Irradiation 3Thiotepa 3Stem Cell Transplantation 3Granulocyte Colony-Stimulating Factor 3Cyclosporine 311-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 3lintuzumab 2Vorinostat 2Peripheral Blood Stem Cell Transplantation 2Patient Reported Outcome Measures 2N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide 2Methotrexate 2Filgrastim 2Alemtuzumab 24-methyl-N-(3-(4-methylimidazol-1-yl)-5-trifluoromethylphenyl)-3-(4-pyrazin-2-ylpyrimidin-2-ylamino)benzamide 2vosaroxin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Hematologic Diseases × Thiotepa × Myeloid × Clear all
NCT04282174 2022-09-27

2019-KOE-001

Baptist Health South Florida

Phase 2 Withdrawn
LymphoidMyeloidOther hematologic neoplasm

Hematologic Diseases, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02660281 2021-11-03

HaploOnly

University of Rochester

Phase 1 Completed
74 enrolled
LymphoidMyeloidPlasma cell

Hematologic Diseases, Lymphoma, Multiple Myeloma, Primary Myelofibrosis

NCT01010217 2020-03-25

Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide

M.D. Anderson Cancer Center

Phase 2 Completed
176 enrolled 18 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Hematologic Diseases, Hodgkin Disease, Leukemia, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡